On November 2-5, the 23rd national annual meeting of the Chinese Society of Psychosomatic Medicine of the Chinese Medical Association and the International Forum on Psychosomatic Medicine, hosted by the Chinese Society of Psychosomatic Medicine, were held in Nanjing. Hansoh Pharma made its appearance at the event by virtue of expert recognition and market reputation gained through its years of intensive work in the psychiatric field.
Site of the 23rd national annual meeting of the Chinese Society of Psychosomatic Medicine of the Chinese Medical Association and the International Forum on Psychosomatic Medicine
In the main venue, Hansoh Pharma's special satellite meeting on Ameining was held at the same time. Experts from the Chinese Society of Psychosomatic Medicine conducted in-depth discussions on the selection of antidepressant drugs based on clinical experience, and spoke highly of the mechanism of action and clinical efficacy of Hansoh's antidepressant product Ameining （Agomelatine Tablets）。 Experts pointed out that Ameining provides a prominent mechanism of action, has few adverse effects, does not produce withdrawal syndrome or addiction, and thus has a good application prospect in the treatment of many mental diseases.
During the meeting, Hansoh Pharma also set up an enterprise display area outside the venue, fully displaying the company's brand and its psychiatric drugs such as Ameining and Oulanning, which attracted many experts to stop and watch. When learning that depression disorder patients nationwide can rely on medical insurance to pay for Ameining since September this year, experts expressed their congratulations and described this as a blessing for the vast number of patients with insomnia and depression as the economic burden of patients can be effectively reduced.
The National Annual Meeting of the Chinese Society of Psychosomatic Medicine of the Chinese Medical Association and the International Forum on Psychosomatic Medicine are the highest-level information communication platform in the field of psychosomatic medicine in China, aiming to promote academic exchanges and cooperation among scholars at home and abroad and to improve the theory and clinical services of psychosomatic medicine across the country through exchange and learning of latest progress and knowledge, concepts and technologies, and psychosomatic diagnosis and treatment countermeasures. On the theme of "Psychosomatic Integrated Diagnosis and Treatment, Communication and Care", this event attracted the participation of more than 1,000 psychosomatic medicine experts and scholars at home and abroad.
Mental health is related to people health, social stability and country development. Over the years, Hansoh Pharma has actively participated in and supported scientific and technological research, academic exchanges and talent development in the field of mental diseases. It has studied and produced a number of generic drugs with excellent efficacy and safety, allowing Chinese people to enjoy the latest achievements in global pharmaceutical development at affordable cost. Also, the company has actively participated in various national and regional psychiatric academic conferences, provided opportunities for peers in the field of psychiatry to learn from each other for improvement, built platforms for the training and development of young talents, and invested heavily to launch the special charity fund for mental health, so as to promote the vigorous development of the national mental health cause through practical actions.
